On November 6, 2024, Nasdaq notified Exela Technologies of its decision to delist the company's common stock, effective November 8, 2024. Consequently, Exela's common stock and Series B Preferred Stock are now traded over-the-counter under symbols "XELA" and "XELAP".On November 19 and 21, 2024, Exela Technologies executed an exchange agreement with certain holders of Series A Preferred Stock, exchanging 1,525,666 shares for 21,385,694 shares of common stock at $1.18 per share. This reduced Series A Preferred Stock from 2,778,111 to 1,252,445 shares and increased common stock from 6,365,363 to 27,751,057 shares.The exchange was approved by a special committee of independent directors, relying on an independent financial advisor's valuation. The transaction was exempt from registration under the Securities Act.

On November 6, 2024, Nasdaq notified Exela Technologies of its decision to delist the company's common stock, effective November 8, 2024. Consequently, Exela's common stock and Series B Preferred Stock are now traded over-the-counter under symbols "XELA" and "XELAP".On November 19 and 21, 2024, Exela Technologies executed an exchange agreement with certain holders of Series A Preferred Stock, exchanging 1,525,666 shares for 21,385,694 shares of common stock at $1.18 per share. This reduced Series A Preferred Stock from 2,778,111 to 1,252,445 shares and increased common stock from 6,365,363 to 27,751,057 shares.The exchange was approved by a special committee of independent directors, relying on an independent financial advisor's valuation. The transaction was exempt from registration under the Securities Act.